nicorandil has been researched along with Cardiac Failure in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.55) | 18.7374 |
| 1990's | 10 (22.73) | 18.2507 |
| 2000's | 9 (20.45) | 29.6817 |
| 2010's | 22 (50.00) | 24.3611 |
| 2020's | 1 (2.27) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Ke, S; Ke, X; Qiu, W; Wu, Y; Zhang, Y | 1 |
| Kobayashi, A; Oikawa, M; Sato, T; Sato, Y; Suzuki, S; Takeishi, Y; Watanabe, S; Yokokawa, T; Yoshihisa, A | 1 |
| Maeba, H; Morishita, S; Shiojima, I; Takehana, K | 1 |
| Li, Z; Liu, C; Wang, H; Wang, X; Wang, Y; Xing, Y; Yue, X; Zhang, W; Zhang, X | 1 |
| Ahmed, LA; El-Maraghy, SA | 1 |
| Ichikawa, S; Iwasaki, T; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Sato, Y; Sumino, H; Toyama, T | 1 |
| Huang, Z; Wu, M; Xie, H; Zhou, Z | 1 |
| Hashimoto, T; Iwamoto, N; Kobayashi, H; Nishida, M; Nishimura, M; Okamoto, Y; Okino, K; Ono, T; Sato, N; Takahashi, H; Tokoro, T; Yamazaki, S | 1 |
| Chaugai, S; Chen, P; Wang, DW; Wang, Y; Zhao, F | 1 |
| Funada, R; Ichikawa, S; Kasama, S; Koitabashi, N; Kurabayashi, M; Matsumoto, N; Sato, Y; Suzuki, Y; Takama, N; Toyama, T | 1 |
| Ahmed, LA; Attia, WA; Khattab, MM; Mohamed, SS | 1 |
| Fukushima, Y; Kumita, S; Sato, N; Tokita, Y | 1 |
| Fujinaga, H; Fujisawa, K; Harada, K; Harada, T; Iima, T; Kageyama, N; Kawata, A; Okada, A; Okumura, T; Saito, A; Shigekiyo, M; Terada, N; Yamamoto, H; Yamamoto, T | 1 |
| Holford, NH; Iida, S; Kinoshita, H | 1 |
| Kajimoto, K; Shimamura, K | 1 |
| Hashimoto, T; Imai, R; Iwamoto, N; Kobayashi, H; Nishida, M; Nishimura, M; Okino, K; Ono, T; Takahashi, H; Tokoro, T; Yamazaki, S | 1 |
| Hagiwara, N; Kajimoto, K; Minami, Y; Nagashima, M; Shiga, T | 1 |
| Inoue, H; Murata, H; Sumikawa, K | 1 |
| Asakura, M; Kitakaze, M | 1 |
| Asanoi, H; Kamijo, T; Katagiri, T; Kato, K; Nakashima, M; Nejima, J; Sakanashi, M; Takano, T; Tanaka, K | 1 |
| Asai, K; Hata, N; Kobayashi, N; Mizuno, K; Shinada, T; Shirakabe, A; Yokoyama, S | 1 |
| Hashimoto, T; Iwamoto, N; Kobayashi, H; Murakawa, M; Nishida, M; Nishimura, M; Okamoto, Y; Ono, T; Sakoda, C; Sato, N; Takahashi, H; Tokoro, T; Yamazaki, S | 1 |
| Fujishima, S; Haga, Y; Ishihara, S; Ishitsuka, T; Kaseda, S; Koga, T; Nyuta, E; Sadoshima, S | 1 |
| Arashi, H; Hagiwara, N; Hattori, H; Higashitani, M; Hoshi, H; Minami, Y; Mizuno, M; Mori, F; Nuki, T; Sashida, Y; Serizawa, N; Shiga, T; Yamada, N; Yamaguchi, J; Yumino, D | 1 |
| Hirasawa, S; Izumi, T; Masuda, R; Masuda, T; Niwano, H; Niwano, S; Sasaki, S; Sato, K | 1 |
| Hirose, M; Kashihara, T; Matsumoto, K; Matsushita, N; Mende, U; Nakada, T; Nishio, A; Sato, F; Shimojo, H; Suzuki, S; Taira, E; Takeishi, Y; Yamada, M | 1 |
| Chang, IK; Chow, SN; Hsieh, FJ; Kau, ML; Ko, YH; Lee, CN; Shyu, MK | 1 |
| Ostrovskiĭ, IuP; Sidorenko, GI | 1 |
| Ichihara, S; Iwase, M; Izawa, H; Murohara, T; Nagasaka, T; Nagata, K; Naoe, T; Noda, A; Obata, K; Xu, J; Yokota, M | 1 |
| Horinaka, S; Kobayashi, N; Matsuoka, H; Mori, Y; Yagi, H | 1 |
| Baxi, A; Codd, V; Galiñanes, M; Hadjinikolaou, L; James, M | 1 |
| Bachert, EL; Fung, HL | 1 |
| Fukai, D; Hisanaga, T; Kinoshita, M; Maeda, K; Maeda, Y; Tsutamoto, T; Wada, A; Yoshida, S | 1 |
| Horie, H; Kinoshita, M; Maeda, Y; Nakae, I; Tsutamoto, T; Wada, A; Yabe, T | 1 |
| Satoh, K | 1 |
| Aarsland, T; Dickstein, K; Gøransson, L; Larsen, AI; Tamby, JF | 1 |
| Koyama, T; Matsuzaki, T; Nakasone, J; Noguchi, K; Ojiri, Y; Sakanashi, M | 1 |
| Clark, AL; Cleland, JG; Coletta, AP; Louis, AA; Manousos, IR | 1 |
| Giles, TD; Hearron, AE; Karalis, DG; Mohrland, JS; Pina, IL; Porter, RS; Quiroz, AC; Roffidal, L; Wolf, DL; Zaleski, R | 1 |
| Bindley, PF; Binkley, PF; Jungbluth, GL; Leier, CV; MacKichan, JJ; Mohrland, JS; Tice, FD; Wolf, DL | 1 |
| Binetti, G; Boriani, G; Boschi, S; Galié, N; Magnani, B; Maiello, L; Varani, E | 1 |
| Binkley, PF; Cody, RJ; Leier, CV; Moeschberger, ML; Mohrland, JS; Tice, FD; Wolf, DL | 1 |
| Bouthier, J; Dahan, M; Gourgon, R; Jaeger, P; Juliard, JM; Solal, AC | 1 |
5 review(s) available for nicorandil and Cardiac Failure
| Article | Year |
|---|---|
Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Female; Heart Failure; Humans; Male; Myocardial Infarction; Nicorandil; Percutaneous Coronary Intervention; PubMed; Risk Factors; Stroke Volume; Thrombolytic Therapy | 2013 |
Effect of nicorandil in patients with heart failure: a systematic review and meta-analysis.
Topics: Blood Pressure; Coronary Circulation; Heart Failure; Heart Rate; Humans; Nicorandil; Vasodilator Agents | 2014 |
[The no-reflow phenomenon and its clinical significance].
Topics: Adenosine; Angioplasty, Balloon, Coronary; Atherectomy; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Heart Failure; Hospital Mortality; Humans; Microvascular Angina; Myocardial Infarction; Nicorandil; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Stents; Vasodilator Agents; Verapamil | 2002 |
[Ca-antagonist, K-channel-opener in the treatment of patients with congestive heart failure].
Topics: Animals; Benzopyrans; Calcium Channel Blockers; Cromakalim; Guanidines; Heart Failure; Hemodynamics; Humans; In Vitro Techniques; Ion Channel Gating; Niacinamide; Nicorandil; Pinacidil; Potassium Channels; Pyrroles; Vasodilator Agents | 1993 |
Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Impact Of Nicorandil on Angina. Combination Assessment of Ranolazine In Stable Angina. ENhancing Recovery In Coronary Heart Disease patients. As
Topics: Acetanilides; Angina Pectoris; Arrhythmias, Cardiac; Cardiology; Clinical Trials as Topic; Comorbidity; Coronary Disease; Defibrillators, Implantable; Depressive Disorder; Electric Countershock; Female; Heart Failure; Humans; Male; Nicorandil; Piperazines; Ranolazine; Sensitivity and Specificity | 2002 |
16 trial(s) available for nicorandil and Cardiac Failure
| Article | Year |
|---|---|
Effectiveness and Safety of Intravenous Nicorandil Application in Patients With Acute Heart Failure With Low Baseline Blood Pressure.
Topics: Biomarkers; Blood Pressure; Heart Failure; Humans; Hypotension; Natriuretic Peptide, Brain; Nicorandil; Peptide Fragments; Prospective Studies; Stroke Volume; Ventricular Function, Left | 2022 |
Clinical potential of oral nicorandil to improve myocardial fatty acid metabolism after percutaneous coronary intervention in hemodialysis patients.
Topics: Aged; Coronary Artery Disease; Death, Sudden, Cardiac; Fatty Acids; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardium; Nicorandil; Percutaneous Coronary Intervention; Renal Dialysis; Renal Insufficiency, Chronic; Survival Rate; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2014 |
Effects of adding intravenous nicorandil to standard therapy on cardiac sympathetic nerve activity and myocyte dysfunction in patients with acute decompensated heart failure.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Myocytes, Cardiac; Nicorandil; Radionuclide Imaging; Sympathetic Nervous System | 2015 |
Intravenous nicorandil for treatment of the urgent phase acute heart failure syndromes: A randomized, controlled trial.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Diastole; Dyspnea; Echocardiography; Emergency Service, Hospital; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Japan; Male; Middle Aged; Nicorandil; Nitroglycerin; Outcome Assessment, Health Care; Prospective Studies; Treatment Outcome; Vasodilator Agents; Ventricular Function, Left | 2017 |
Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Nicorandil; Postoperative Complications; Prospective Studies; Renal Dialysis; Vasodilator Agents | 2009 |
Acute efficacy and safety of intravenous administration of nicorandil in patients with acute heart failure syndromes: usefulness of noninvasive echocardiographic hemodynamic evaluation.
Topics: Acute Disease; Aged; Aged, 80 and over; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Nicorandil; Syndrome; Treatment Outcome; Vasodilator Agents | 2009 |
Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure.
Topics: Acute Disease; Aged; Female; Heart Failure; Hemodynamics; Hospitalization; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Nicorandil; Pulmonary Wedge Pressure; Vasodilator Agents | 2010 |
Efficacy and safety of nicorandil therapy in patients with acute heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Female; Heart Failure; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Nicorandil; Peptide Fragments; Vasodilator Agents | 2010 |
Effects of intravenous nicorandil on the mid-term prognosis of patients with acute heart failure syndrome.
Topics: Acute Disease; Age Factors; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Male; Nicorandil; Retrospective Studies; Survival Rate; Syndrome | 2012 |
Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes.
Topics: Aged; Aged, 80 and over; Atrial Natriuretic Factor; Chi-Square Distribution; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Japan; Male; Middle Aged; Nicorandil; Syndrome; Time Factors; Treatment Outcome; Vasodilator Agents | 2013 |
Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
Topics: Adult; Aged; Analysis of Variance; Blood Pressure; Cyclic GMP; Female; Heart Failure; Hemodynamics; Humans; Least-Squares Analysis; Male; Middle Aged; Niacinamide; Nicorandil; Nitroglycerin; Pulmonary Wedge Pressure; Regression Analysis; Vasodilator Agents | 1995 |
Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Nitroglycerin; Pulmonary Wedge Pressure; Vasodilator Agents | 1994 |
Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
Topics: Aged; Cross-Over Studies; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Niacinamide; Nicorandil; Nitroglycerin; Treatment Outcome; Vasodilator Agents | 1997 |
Clinical pharmacology of nicorandil in patients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Cardiovascular System; Double-Blind Method; Female; Half-Life; Heart Failure; Humans; Least-Squares Analysis; Male; Middle Aged; Niacinamide; Nicorandil; Vasodilator Agents | 1992 |
Usefulness of nicorandil in congestive heart failure.
Topics: Adult; Double-Blind Method; Exercise; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Randomized Controlled Trials as Topic; Time Factors; Vasodilator Agents | 1990 |
Hemodynamic effects of oral nicorandil in congestive heart failure.
Topics: Administration, Oral; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Randomized Controlled Trials as Topic; Vasodilator Agents | 1990 |
23 other study(ies) available for nicorandil and Cardiac Failure
| Article | Year |
|---|---|
Decreased cardiac mortality with nicorandil in patients with ischemic heart failure.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Vasodilator Agents | 2017 |
Nicorandil was an Effective Treatment Option for a Patient with Bland-White-Garland Syndrome.
Topics: Aged; Bland White Garland Syndrome; Female; Heart Failure; Humans; Myocardial Ischemia; Nicorandil; Treatment Outcome; Vasodilator Agents | 2017 |
Protective Effects of Nicorandil on Cardiac Function and Left Ventricular Remodeling in a Rat Model of Ischemic Heart Failure.
Topics: Animals; bcl-2-Associated X Protein; Cardiotonic Agents; Heart Failure; Heart Ventricles; Male; Myocardial Ischemia; Myocardium; Nicorandil; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2018 |
Nicorandil ameliorates mitochondrial dysfunction in doxorubicin-induced heart failure in rats: possible mechanism of cardioprotection.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Ehrlich Tumor; Cardiotonic Agents; Caspase 3; Cytochromes c; DNA Fragmentation; Doxorubicin; Heart Failure; Heart Rate; Male; Mice; Mitochondria; Myocardium; Nicorandil; Oxidative Phosphorylation; Rats; Rats, Wistar | 2013 |
Effects of oral nicorandil therapy on sympathetic nerve activity and cardiac events in patients with chronic heart failure: subanalysis of our previous report using propensity score matching.
Topics: 3-Iodobenzylguanidine; Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Death; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nicorandil; Organ Size; Prognosis; Radionuclide Imaging; Sympathetic Nervous System | 2014 |
Nicorandil enhances the efficacy of mesenchymal stem cell therapy in isoproterenol-induced heart failure in rats.
Topics: Animals; Cardiovascular Agents; Drug Therapy, Combination; Heart Failure; Isoproterenol; Male; Mesenchymal Stem Cell Transplantation; Nicorandil; Rats; Rats, Wistar | 2015 |
Prognostic Value of Myocardial Perfusion SPECT After Intravenous Bolus Administration of Nicorandil in Patients with Acute Ischemic Heart Failure.
Topics: Aged; Aged, 80 and over; Exercise Test; Female; Heart; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Nicorandil; Positron-Emission Tomography; Prognosis; Rest; Risk Factors; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2016 |
Population pharmacokinetic and pharmacodynamic modelling of the effects of nicorandil in the treatment of acute heart failure.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Middle Aged; Models, Biological; Nicorandil; Nonlinear Dynamics; Predictive Value of Tests; Pulmonary Wedge Pressure; Treatment Outcome | 2008 |
Acute efficacy of combined therapy of carperitide and nicorandil for acute decompensated heart failure with left ventricular systolic dysfunction.
Topics: Acute Disease; Atrial Natriuretic Factor; Drug Therapy, Combination; Female; Heart Failure; Humans; Middle Aged; Nicorandil; Treatment Outcome; Ventricular Dysfunction, Left | 2011 |
Anesthetic management of a patient undergoing liver transplantation who had previous coronary artery bypass grafting using an in situ right gastroepiploic artery.
Topics: Anesthesia; Anti-Arrhythmia Agents; Cardiotonic Agents; Coronary Artery Bypass; Gastroepiploic Artery; Heart Failure; Humans; Imidazoles; Liver Transplantation; Male; Middle Aged; Nicorandil; Pyridones | 2010 |
Cardioprotection in the clinical setting-lessons from J-WIND studies.
Topics: Atrial Natriuretic Factor; Cardiotonic Agents; Disease Progression; Heart Failure; Humans; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Nicorandil; Randomized Controlled Trials as Topic; Risk Factors; Vasodilator Agents | 2010 |
Oral nicorandil for prevention of cardiac death in hemodialysis patients without obstructive coronary artery disease: a propensity-matched patient analysis.
Topics: Administration, Oral; Aged; Cardiovascular Agents; Coronary Angiography; Coronary Disease; Death, Sudden, Cardiac; Drug Evaluation; Female; Follow-Up Studies; Heart Failure; Humans; Insulin Resistance; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Nicorandil; Proportional Hazards Models; Renal Dialysis; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2011 |
Cardioprotective effects of sarcolemmal and mitochondrial K-ATP channel openers in an experimental model of autoimmune myocarditis. Role of the reduction in calcium overload during acute heart failure.
Topics: Action Potentials; Acute Disease; Animals; Anti-Arrhythmia Agents; Autoimmune Diseases; Calcium; Echocardiography; Electrophysiology; Heart Failure; KATP Channels; Mexiletine; Mitochondria, Heart; Myocarditis; Nicorandil; Rats; Sarcolemma; Ventricular Function, Left | 2012 |
Nicorandil prevents Gαq-induced progressive heart failure and ventricular arrhythmias in transgenic mice.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomegaly; Electrocardiography; Female; Fibrosis; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; KATP Channels; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Nicorandil; Nitric Oxide Synthase; RNA, Messenger; TRPC Cation Channels; Ventricular Premature Complexes | 2012 |
Prenatal diagnosis and treatment of fetal long QT syndrome: a case report.
Topics: Adult; Bradycardia; Bundle-Branch Block; Electrocardiography; Female; Fetal Diseases; Heart Block; Heart Failure; Humans; Infant, Newborn; Lidocaine; Long QT Syndrome; Male; Nicorandil; Pregnancy; Pregnancy Trimester, Second; Propranolol; Tachycardia, Ventricular; Ultrasonography, Prenatal; Vasodilator Agents | 2002 |
Nicorandil promotes myocardial capillary and arteriolar growth in the failing heart of Dahl salt-sensitive hypertensive rats.
Topics: Animals; Antihypertensive Agents; Arteries; Capillaries; Coronary Vessels; Echocardiography; Fibroblast Growth Factor 2; Gene Expression; Heart Failure; Hemodynamics; Hypertension; Male; Myocardium; Nicorandil; Nitric Oxide Synthase Type III; Rats; Rats, Inbred Dahl; Receptors, Vascular Endothelial Growth Factor; Sodium Chloride; Vascular Endothelial Growth Factor A; Ventricular Remodeling | 2005 |
Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiac Volume; Heart Failure; Hypertension; Isosorbide Dinitrate; Male; Nicorandil; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Potassium Channels; Rats; Rats, Inbred Dahl; RNA, Messenger; Up-Regulation; Ventricular Remodeling | 2006 |
TNF-alpha gene promoter polymorphism at nucleotide -308 and the inflammatory response and oxidative stress induced by cardiac surgery: role of heart failure and medical treatment.
Topics: Aged; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Female; Heart Failure; Humans; Inflammation Mediators; Lymphocytes; Male; Middle Aged; Nicorandil; Oxidative Stress; Peroxynitrous Acid; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2008 |
Hemodynamic tolerance and pharmacokinetics of nicorandil in experimental heart failure.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Chromatography, High Pressure Liquid; Heart Failure; Heart Rate; Hemodynamics; Male; Niacinamide; Nicorandil; Rats; Rats, Sprague-Dawley | 1993 |
Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim.
Topics: Acute Disease; Animals; Blood Pressure; Coronary Circulation; Cromakalim; Disease Models, Animal; Dogs; Female; Heart; Heart Failure; Heart Rate; Male; Myocardial Contraction; Myocardium; Niacinamide; Nicorandil; Nitroglycerin; Saponins; Vasodilator Agents | 1998 |
Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans.
Topics: Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Neurotransmitter Agents; Niacinamide; Nicorandil; Norepinephrine; Pulmonary Wedge Pressure; Renin; Vasodilator Agents | 1992 |
A symposium: A new treatment for angina pectoris and heart failure. October 17, 1987, San Francisco. Proceedings.
Topics: Angina Pectoris; Animals; Heart Failure; Humans; Niacinamide; Nicorandil; Vasodilator Agents | 1989 |
Hemodynamic action of nicorandil in chronic congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Pulmonary Wedge Pressure; Vascular Resistance; Vasodilator Agents | 1989 |